Legacy Labs LLC Releases Latest Cognizine Review from Brain Injury Survivor Bill Rose
Studies performed by the Alzheimer's Society indicate at least 20 percent of Americans suffer from a condition known as Mild Cognitive Impairment during adulthood. Causing varying degrees of difficulty in the areas of memory, language, routine planning, attention span and visual recognition, this dissolution of basic cognitive function can be a disruptive force in daily life and can lead to an increased risk for developing dementia later in life. In an effort to increase public awareness of a powerful tool in the fight against MCI, Legacy Labs, LLC has launched their latest review during which Bill Rose, brain injury survivor, gives his testimonial for Cognizine.